Anondita Medicare IPO GMP, Price, Allotment, Listing & Subscription Details

The Anondita Medicare IPO is generating strong investor interest in the SME segment. With a healthy Grey Market Premium (GMP) trend, the IPO is being closely tracked for potential listing gains. Let’s explore the latest Anondita Medicare IPO GMP, subscription details, and all key information investors need.

Anondita Medicare IPO GMP Today

As of August 21, 2025 (03:36 PM), the Anondita Medicare IPO GMP is ₹50 per share. Considering the IPO’s upper price band of ₹145, the estimated listing price is around ₹195 per share, which indicates a potential gain of 34.48%.

This strong premium in the grey market shows positive investor sentiment and hints at a possible robust listing on the NSE SME platform.

Anondita Medicare IPO Details

• IPO Type: Book Built Issue

• Total Issue Size: ₹69.50 crores

• Fresh Issue: 0.48 crore shares (₹69.50 crores)

• Offer for Sale (OFS): Nil

• Price Band: ₹137 – ₹145 per share

• Lot Size: 1,000 shares

• Minimum Investment (Retail): ₹2,74,000 (2 lots = 2,000 shares)

• Minimum Investment (HNI): 3 lots (3,000 shares) = ₹4,35,000

Anondita Medicare IPO Important Dates

• Bidding Opens: August 22, 2025

• Bidding Closes: August 26, 2025

• Allotment Date: August 28, 2025

• Refunds Initiation: August 29, 2025

• Listing Date (Tentative): September 1, 2025

• Exchange: NSE SME
  
  

Should You Apply in Anondita Medicare IPO?

The Anondita Medicare IPO GMP clearly reflects strong demand, with an estimated 34% potential gain on listing. This makes it an attractive opportunity for short-term investors eyeing listing benefits.

However, as with all IPOs, investors should also consider:

• Company’s fundamentals and financial track record

• Growth prospects in the healthcare & pharma sector

• Valuation compared to industry peers

• Subscription demand across retail, QIB, and HNI categories
  
  

A combination of strong GMP and sound fundamentals could make this IPO a rewarding bet.

Conclusion

The Anondita Medicare IPO GMP at ₹50 per share indicates strong listing potential, with an estimated price of ₹195 per share against the cap price of ₹145. With over 34% expected gains, this IPO is drawing significant interest from SME investors.

Still, investors should balance GMP expectations with a detailed review of company performance and market conditions before applying.